Physician profile
Mey Yip
NPI 1336671825
$1,008.86
in general payments reported to CMS, 2019-2025
16 companies · $623 in 2025
The $623 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.89 · 2024: $295 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $162.55 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $158.88 | 2025 | Annovera |
| Abbvie INC. | $107.78 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $90.35 | 2024-2025 | |
| Exeltis, USA INC. | $83.67 | 2024-2025 | Slynd |
| Hologic Sales and Service, LLC | $59.48 | 2024 | Aptima, Thinprep 2000 Processor |
| Merck Sharp & Dohme LLC | $52.12 | 2024-2025 | Gardasil 9, Gardasil |
| Organon LLC | $48.65 | 2024-2025 | Nexplanon |
| Caris Mpi, INC. | $40.85 | 2025 | Mi Cancer Seek |
| Millicent US INC | $40.05 | 2025 | Femlyv, Intrarosa |
| Astellas Pharma US INC | $34.04 | 2025 | Veozah |
| Agile Therapeutics, INC. | $33.52 | 2024 | Twirla |
| Meditrina | $26.05 | 2024 | |
| Supernus Pharmaceuticals, INC. | $24.60 | 2025 | Qelbree |
| Coopersurgical, INC. | $23.29 | 2024 | Sos |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $22.98 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mey Yip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.